X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Search

Type in a keyword to search

On page 1 showing 1 ~ 8 term(s) out of 8 term(s)

Snippet view Table view


    Carbachol

    Description: A slowly hydrolyzed cholinergic agonist that acts at both muscarinic and nicotinic receptors. (PubChem) Pharmacology: Carbachol is a potent cholinergic (parasympathomimetic) agent which produces constriction of the iris and ciliary body resulting in reduction in intraocular pressure. The exact mechanism by which carbachol lowers intraocular pressure is not precisely known. In the cat and rat, carbachol is well-known for its ability to induce rapid eye movement (REM) sleep when microinjected into the pontine reticular formation. Carbachol elicits this REM sleep-like state via activation of postsynaptic muscarinic cholinergic receptors (mAChRs). Mechanism of action: Carbachol is a parasympathomimetic that stimulates both muscarinic and nicotinic receptors. In topical ocular and intraocular administration its principal effects are miosis and increased aqueous humour outflow. Drug type: Approved. Small Molecule. Drug category: Analgesics, Non-Narcotic. Cardiotonic Agents. Cholinergic Agonists. Miotics

    Preferred ID: CHEBI:3385     Type: term      ID# ILX:0101647     Score: 23398.777


    Carbachol

    Description: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

    Preferred ID: MESH:M0003323     Type: term      ID# ILX:0737226     Score: 23292.383


    Related to Relationship

    Description:

    Preferred ID: ILX:0112796     Type: relationship      ID# ILX:0112796     Score: 8.195149


    Has role Relationship

    Description:

    Preferred ID: ILX:0112784     Type: relationship      ID# ILX:0112784     Score: 7.858898


    Alpha 3 Acetylcholine Receptor

    Description: Neuronal acetylcholine receptor subunit alpha-3 is encoded by the human CHRNA3 gene. This protein plays a role in ion transport. After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Neuronal AChR is composed of two different types of subunits: alpha and beta. Alpha-3 subunit can be combined to beta-2 or beta-4 to give rise to functional receptors. Interacts with RIC3; which is required for proper folding and assembly. (Adapted from NCBI and Swiss-Prot).

    Preferred ID: SAO:99825125     Type: term      ID# ILX:0100486     Score: 7.85434


    Cholinergic system

    Description: any molecule, protein, cell, tissue or organ that is related to acetylcholine.

    Preferred ID: UBERON:0025595     Type: term      ID# ILX:0102133     Score: 7.8243127


    Drug

    Description: Any substance which when absorbed into a living organism may modify one or more of its functions. The term is generally accepted for a substance taken for a therapeutic purpose, but is also commonly used for abused substances.

    Preferred ID: CHEBI:23888     Type: term      ID# ILX:0103576     Score: 7.6843243


    Bethanechol

    Description: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, cardiac rate changes, and bronchial spasms. (PubChem) Pharmacology: Bethanechol is a parasympathomimetic (cholinergic) used for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. Bethanechol, a cholinergic agent, is a synthetic ester which is structurally and pharmacologically related to acetylcholine. It increases the tone of the detrusor urinae muscle, usually producing a contraction sufficiently strong to initiate micturition and empty the bladder. It stimulates gastric motility, increases gastric tone, and often restores impaired rhythmic peristalsis. Bethanechol chloride is not destroyed by cholinesterase and its effects are more prolonged than those of acetytcholine. Mechanism of action: Bethanechol acts by selectively stimulating muscarinic receptors in the parasympathetic nervous system, inducing no affect on nicotinic receptors. Drug type: Approved. Small Molecule. Drug category: Muscarinic Agonists. Parasympathomimetics

    Preferred ID: ILX:0101259     Type: term      ID# ILX:0101259     Score: 6.828768


X

Are you sure you want to delete that component?